Can atenolol (beta-blocker) be discontinued and metoprolol (beta-blocker) be started in its place?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Atenolol to Metoprolol

Yes, atenolol can be safely discontinued and replaced with metoprolol, but this switch should follow a structured approach to avoid cardiovascular risks. 1, 2

Rationale for Switching

  • Metoprolol (particularly metoprolol succinate) is preferred over atenolol for heart failure patients as it is one of the three beta-blockers proven to reduce mortality, along with bisoprolol and carvedilol 1
  • Atenolol should be avoided in patients with hypertension who are pregnant or planning pregnancy due to its association with lower birth weight 1
  • Metoprolol has better evidence for cardiovascular outcomes compared to atenolol, which is specifically mentioned as not preferred in heart failure 1

Switching Protocol

Step 1: Assessment Before Switch

  • Evaluate current heart rate, blood pressure, and symptoms of heart failure or cardiovascular disease 1, 2
  • Check for contraindications to metoprolol including severe bradycardia, heart block, cardiogenic shock, or active asthma 2

Step 2: Initiation of Metoprolol

  • Start metoprolol while gradually tapering atenolol over 1-2 weeks 2
  • For metoprolol tartrate: Begin with 25-50 mg twice daily 2, 3
  • For metoprolol succinate (extended-release): Begin with 50 mg once daily 2

Step 3: Tapering Atenolol

  • Reduce atenolol dose by 25-50% every 1-2 weeks while increasing metoprolol 2
  • Complete overlap approach is preferred to avoid rebound effects 4
  • Never stop atenolol abruptly as this can cause rebound hypertension or worsening angina 1, 5

Step 4: Monitoring During Transition

  • Monitor blood pressure and heart rate closely during the transition period 2
  • Watch for signs of worsening heart failure, including fluid retention or increased fatigue 1
  • Target heart rate of 50-60 beats per minute unless limiting side effects occur 2

Dosing Equivalence

  • 50 mg atenolol once daily is approximately equivalent to 100 mg metoprolol tartrate (standard release) in antihypertensive effect 3, 6
  • Metoprolol tartrate may require twice-daily dosing for optimal 24-hour coverage, while metoprolol succinate provides effective once-daily dosing 7

Special Considerations

  • If patient has heart failure, the preferred beta-blockers are bisoprolol, carvedilol, or metoprolol succinate (not metoprolol tartrate) 1
  • If marked fatigue or bradycardia occurs during transition, temporarily reduce the dose of the beta-blocker and review the patient in 1-2 weeks 1
  • If heart rate drops below 50 bpm with worsening symptoms, halve the dose of beta-blocker 1
  • For patients with symptomatic hypotension during transition, consider reducing doses of other vasodilators or diuretics first 1

Important Cautions

  • Beta-blockers should never be stopped suddenly unless absolutely necessary due to risk of rebound ischemia, infarction, or arrhythmias 1
  • If serious deterioration occurs during transition, seek specialist advice 1
  • Patients with severe heart failure (NYHA Class III/IV) should be referred for specialist care during beta-blocker transitions 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.